Tempus AI CEO Eric Lefkofsky sells $62m in inventory

Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. (NASDAQ:TEM), lately offered a good portion of his holdings, totaling roughly $62 million in worth. The transactions, disclosed in a Type 4 submitting with the Securities and Trade Fee, occurred over a number of days. The gross sales come amid a exceptional 46% surge in TEM’s inventory worth over the previous week. In response to InvestingPro, the corporate, at present valued at $8.63 billion, has proven sturdy momentum regardless of working at a loss.

On January 22, Lefkofsky offered a sequence of shares at costs starting from $47.78 to $51.82. These gross sales included 30,609 shares at $47.78, 101,967 shares at $49.06, and 238,699 shares at $49.84. Extra transactions included 60,587 shares at $50.70 and 41,747 shares at $51.82.

The next day, January 23, noticed additional gross sales with 24,677 shares offered at $48 and 61,987 shares at $48.57. Notably, a bigger transaction concerned 365,467 shares at $52.79.

On January 24, Lefkofsky continued the pattern, promoting 71,333 shares at $53.26 and 11,355 shares at $53.84. The ultimate transaction for that day concerned 3,100 shares offered at $54.75.

These transactions had been a part of a mandated “promote to cowl” to satisfy tax obligations associated to the vesting of restricted inventory models, as famous within the submitting. Following these gross sales, Lefkofsky retains possession of a number of million shares, each immediately and not directly by way of varied entities. InvestingPro subscribers can entry extra insights, together with 8 extra ProTips and detailed monetary metrics for TEM.

In different latest information, Tempus AI, a healthcare AI firm, has reported spectacular income development of 30% for 2024, with whole revenues of roughly $693 million. The fourth quarter alone noticed revenues of about $200 million, representing a 35% rise year-over-year. The corporate has additionally launched a private well being concierge app, Olivia, geared toward centralizing affected person well being information and offering AI-driven insights. Moreover, Tempus AI has introduced the event of a whole-genome sequencing check, named xH, at present obtainable for analysis functions and anticipated to be clinically obtainable inside the subsequent yr. By way of analyst updates, Loop Capital trimmed its worth goal on Tempus AI from $57.00 to $52.00, whereas sustaining a Purchase ranking. Equally, Piper Sandler raised the value goal for Tempus AI from $40 to $70, sustaining a impartial ranking. Stifel, nonetheless, downgraded Tempus AI’s inventory from Purchase to Maintain however elevated the value goal to $65. These are latest developments for Tempus AI.

This text was generated with the assist of AI and reviewed by an editor. For extra data see our T&C.